Literature DB >> 29453243

Peak perihemorrhagic edema correlates with functional outcome in intracerebral hemorrhage.

Bastian Volbers1, Antje Giede-Jeppe2, Stefan T Gerner2, Jochen A Sembill2, Joji B Kuramatsu2, Stefan Lang2, Hannes Lücking2, Dimitre Staykov2, Hagen B Huttner2.   

Abstract

OBJECTIVE: To evaluate the association of perihemorrhagic edema (PHE) evolution and peak edema extent with day 90 functional outcome in patients with intracerebral hemorrhage (ICH) and identify pathophysiologic factors influencing edema evolution.
METHODS: This retrospective cohort study included patients with spontaneous supratentorial ICH between January 2006 and January 2014. ICH and PHE volumes were studied using a validated semiautomatic volumetric algorithm. Multivariable logistic regression and propensity score matching (PSM) accounting for age, ICH volume, and location were used for assessing measures associated with functional outcome and PHE evolution. Clinical outcome on day 90 was assessed using the modified Rankin Scale (0-3 = favorable, 4-6 = poor).
RESULTS: A total of 292 patients were included. Median age was 70 years (interquartile range [IQR] 62-78), median ICH volume on admission 17.7 mL (IQR 7.9-40.2). Besides established factors for functional outcome, i.e., ICH volume and location, age, intraventricular hemorrhage, and NIH Stroke Scale score on admission, multivariable logistic regression revealed peak PHE volume (odds ratio [OR] 0.984 [95% confidence interval (CI) 0.973-0.994]) as an independent predictor of day 90 outcome. Peak PHE volume was independently associated with initial PHE increase up to day 3 (OR 1.060 [95% CI 1.018-1.103]) and neutrophil to lymphocyte ratio on day 6 (OR 1.236 [95% CI 1.034-1.477; PSM cohort, n = 124]). Initial PHE increase (PSM cohort, n = 224) was independently related to hematoma expansion (OR 3.647 [95% CI 1.533-8.679]) and fever burden on days 2-3 (OR 1.456 [95% CI 1.103-1.920]).
CONCLUSION: Our findings suggest that peak PHE volume represents an independent predictor of functional outcome after ICH. Inflammatory processes and hematoma expansion seem to be involved in PHE evolution and may represent important treatment targets.
© 2018 American Academy of Neurology.

Entities:  

Mesh:

Year:  2018        PMID: 29453243     DOI: 10.1212/WNL.0000000000005167

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  24 in total

Review 1.  Perihematomal edema: Implications for intracerebral hemorrhage research and therapeutic advances.

Authors:  Magdy Selim; Casey Norton
Journal:  J Neurosci Res       Date:  2018-12-21       Impact factor: 4.164

Review 2.  [Acute treatment of intracerebral hemorrhage].

Authors:  J A Sembill; J B Kuramatsu
Journal:  Med Klin Intensivmed Notfmed       Date:  2019-08-29       Impact factor: 0.840

3.  Potential therapeutic targets for intracerebral hemorrhage-associated inflammation: An update.

Authors:  Honglei Ren; Ranran Han; Xuemei Chen; Xi Liu; Jieru Wan; Limin Wang; Xiuli Yang; Jian Wang
Journal:  J Cereb Blood Flow Metab       Date:  2020-05-19       Impact factor: 6.200

4.  Relationship Between Hematoma Expansion Induced by Hypertension and Hyperglycemia and Blood-brain Barrier Disruption in Mice and Its Possible Mechanism: Role of Aquaporin-4 and Connexin43.

Authors:  Heling Chu; Zidan Gao; Chuyi Huang; Jing Dong; Yuping Tang; Qiang Dong
Journal:  Neurosci Bull       Date:  2020-07-05       Impact factor: 5.203

Review 5.  [Intracerebral hemorrhage: hot topics].

Authors:  Maximilian I Sprügel; Hagen B Huttner
Journal:  Nervenarzt       Date:  2019-10       Impact factor: 1.214

6.  Systemic inflammation status at admission affects the outcome of intracerebral hemorrhage by increasing perihematomal edema but not the hematoma growth.

Authors:  Sérgio Fonseca; Francisca Costa; Mafalda Seabra; Rafael Dias; Adriana Soares; Celeste Dias; Elsa Azevedo; Pedro Castro
Journal:  Acta Neurol Belg       Date:  2020-01-07       Impact factor: 2.396

Review 7.  Impact of Recent Studies for the Treatment of Intracerebral Hemorrhage.

Authors:  Jochen A Sembill; Hagen B Huttner; Joji B Kuramatsu
Journal:  Curr Neurol Neurosci Rep       Date:  2018-08-20       Impact factor: 5.081

8.  Intensive Blood Pressure Reduction and Perihematomal Edema Expansion in Deep Intracerebral Hemorrhage.

Authors:  Audrey C Leasure; Adnan I Qureshi; Santosh B Murthy; Hooman Kamel; Joshua N Goldstein; Kyle B Walsh; Daniel Woo; Fu-Dong Shi; Hagen B Huttner; Wendy C Ziai; Daniel F Hanley; Charles C Matouk; Lauren H Sansing; Guido J Falcone; Kevin N Sheth
Journal:  Stroke       Date:  2019-07-05       Impact factor: 7.914

9.  Statins and perihemorrhagic edema in patients with spontaneous intracerebral hemorrhage.

Authors:  Jens Witsch; Fawaz Al-Mufti; E Sander Connolly; Sachin Agarwal; Kara Melmed; David J Roh; Jan Claassen; Soojin Park
Journal:  Neurology       Date:  2019-02-06       Impact factor: 9.910

10.  Oedema extension distance in intracerebral haemorrhage: Association with baseline characteristics and long-term outcome.

Authors:  Robert Hurford; Andy Vail; Calvin Heal; Wendy C Ziai; Jesse Dawson; Santosh B Murthy; Xia Wang; Craig S Anderson; Daniel F Hanley; Adrian R Parry-Jones
Journal:  Eur Stroke J       Date:  2019-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.